Korean J Urol.  2011 Nov;52(11):763-768.

Comparative Analysis of the Efficacy and Safety of Conventional Transurethral Resection of the Prostate, Transurethral Resection of the Prostate in Saline (TURIS), and TURIS-Plasma Vaporization for the Treatment of Benign Prostatic Hyperplasia: A Pilot Study

• Lee YT
• Ryu YW
• Lee DM
• Park SW
• Yum SH
• Han JH

Abstract

PURPOSE
This study was conducted to perform a comparative analysis of the efficacy and safety of conventional transurethral resection of the prostate (TUR-P), transurethral resection in saline (TURIS), and TURIS-plasma vaporization (TURIS-V) when performed by a single surgeon for benign prostatic hyperplasia (BPH).
MATERIALS AND METHODS
The clinical data of 73 consecutive men who underwent conventional TUR-P (39), TURIS (19), or TURIS-V (15) for BPH were retrospectively analyzed. All procedures were carried out by a single surgeon between October 2007 and April 2010. The patients were assessed preoperatively and perioperatively and were followed at 1, 3, and 6 months postoperatively. Patient baseline characteristics, perioperative data, and postoperative outcomes were compared, and major complications were recorded.
RESULTS
In all groups, significant improvements in subjective and objective voiding parameters were achieved and were sustained throughout follow-up. TURIS-V had the shortest operation time compared with conventional TUR-P and TURIS (p=0.211). TURIS-V significantly decreased procedural irrigation fluid volume, postoperative irrigation duration, catheter duration, and hospital stay compared with conventional TUR-P and TURIS. There were no significant differences between the groups in hemoglobin levels or serum sodium levels before and after the operations. There were three transfusions and four clot retentions in the TUR-P group, and one transfusion and one clot retention in the TURIS group. The TURIS-V group had no complications.
CONCLUSIONS
TURIS and TURIS-V were effective for the surgical treatment of BPH in addition to conventional TUR-P. TURIS-V was not inferior to conventional TUR-P or TURIS in terms of safety.

Keyword

Male; Prostatectomy; Prostatic hyperplasia; Transurethral resection of prostate; Urologic surgical procedures

MeSH Terms

Catheters
Follow-Up Studies
Hemoglobins
Humans
Length of Stay
Male
Pilot Projects
Prostate
Prostatectomy
Prostatic Hyperplasia
Retention (Psychology)
Retrospective Studies
Sodium
Transurethral Resection of Prostate
Urologic Surgical Procedures
Volatilization
Hemoglobins
Sodium

Figure

• 

  FIG. 1 Postoperative follow-up outcome parameters according to the operation methods: transurethral resection of the prostate (TUR-P), transurethral resection of the prostate in saline (TURIS), and TURIS-plasma vaporization (TURIS-V). (A) International Prostate Symptom Score (IPSS), (B) quality of life (QoL), (C) Maximal urinary flow rate (Qmax), (D) postvoiding residual urine (PVR), a: p<0.01, b: p<0.05, c: p>0.05 (preoperative value vs. present value, Student's t-test).

Reference

1. Lee HL, Seo JW, Kim WJ. The prevalence of benign prostatic hyperplasia: community-base study in Chungbuk province. Korean J Urol. 1999. 40:1500–1505.

2. Lee E, Yoo KY, Kim Y, Shin Y, Lee C. Prevalence of lower urinary tract symptoms in Korean men in a community-based study. Eur Urol. 1998. 33:17–21.

3. Geavlete B, Multescu R, Dragutescu M, Jecu M, Georgescu D, Geavlete P. Transurethral resection (TUR) in saline plasma vaporization of the prostate vs standard TUR of the prostate: 'the better choice' in benign prostatic hyperplasia? BJU Int. 2010. 106:1695–1699.

4. Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. Eur Urol. 2006. 50:969–979.

5. Oelke M, Alivizatos G, Emberton M, Gravas S, Madersbacher S, Michel M, et al. Parsons KF, Irani J, Chapple CR, Fall M, Hanus J, Llorente Abarca C, editors. Guideline on benign prostatic hyperplasia. European Association of Urology Pocket Guideline. 2009. Arnhem: European Association of urology;90–97.

6. Robert G, Descazeaud A, Delongchamps NB, Ballereau C, Haillot O, Saussine C, et al. Transurethral plasma vaporization of the prostate: 3-month functional outcome and complications. BJU Int. 2010. Epub ahead of print.

7. Madersbacher S, Lackner J, Brössner C, Röhlich M, Stancik I, Willinger M, et al. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Eur Urol. 2005. 47:499–504.

8. Ho HS, Yip SK, Lim KB, Fook S, Foo KT, Cheng CW. A prospective randomized study comparing monopolar and bipolar transurethral resection of prostate using transurethral resection in saline (TURIS) system. Eur Urol. 2007. 52:517–522.

9. Starkman JS, Santucci RA. Comparison of bipolar transurethral resection of the prostate with standard transurethral prostatectomy: shorter stay, earlier catheter removal and fewer complications. BJU Int. 2005. 95:69–71.

10. Kim SW, Ku JH, Park K, Son H, Paick JS. A different female partner does not affect the success of second vasectomy reversal. J Androl. 2005. 26:48–52.

11. Masumori N, Kamoto T, Seki N, Homma Y. Committee for Clinical Guideline for Benign Prostatic Hyperplasia. Surgical procedures for benign prostatic hyperplasia: a nationwide survey in Japan. Int J Urol. 2011. 18:166–170.

12. Kang JY, Min GE, Son H, Kim HT, Lee HL. National-wide data on the treatment of BPH in Korea. Prostate Cancer Prostatic Dis. 2011. Epub ahead of print.

13. Nora L, Hui X, Lori L. Trends in surgical management for benign prostatic hyperplasia. J Urol (Suppl). 2011. 185:e838.

14. ElMalik EM, Ibrahim AI, Gahli AM, Saad MS, Bahar YM. Risk factors in prostatectomy bleeding: preoperative urinary infection is the only reversible factor. Eur Urol. 2000. 37:199–204.

15. Chen Q, Zhang L, Fan QL, Zhou J, Peng YB, Wang Z. Bipolar transurethral resection in saline vs traditional monopolar resection of the prostate: results of a randomized trial with a 2-year follow-up. BJU Int. 2010. 106:1339–1343.

16. Hon NH, Brathwaite D, Hussain Z, Ghiblawi S, Brace H, Hayne D, et al. A prospective, randomized trial comparing conventional transurethral prostate resection with PlasmaKinetic vaporization of the prostate: physiological changes, early complications and long-term followup. J Urol. 2006. 176:205–209.

17. Karaman MI, Kaya C, Ozturk M, Gurdal M, Kirecci S, Pirincci N. Comparison of transurethral vaporization using Plasma Kinetic energy and transurethral resection of prostate: 1-year follow-up. J Endourol. 2005. 19:734–737.

18. Patankar S, Jamkar A, Dobhada S, Gorde V. PlasmaKinetic Superpulse transurethral resection versus conventional transurethral resection of prostate. J Endourol. 2006. 20:215–219.

19. Geavlete B, Multescu R, Dragutescu M, Jecu M, Georgescu D, Geavlete P. Transurethral resection (TUR) in saline plasma vaporization of the prostate vs standard TUR of the prostate: the better choice' in benign prostatic hyperplasia? BJU Int. 2010. 106:1695–1699.